[go: up one dir, main page]

FI935066L - 2-amino-1,2,3,4-tetrahydronaftalenderivat aktivt inverkande pao kardiovaskularsystemet, foerfaranden foer framstaellning av dem och farmaceutiska kompositioner innehaollande dem - Google Patents

2-amino-1,2,3,4-tetrahydronaftalenderivat aktivt inverkande pao kardiovaskularsystemet, foerfaranden foer framstaellning av dem och farmaceutiska kompositioner innehaollande dem Download PDF

Info

Publication number
FI935066L
FI935066L FI935066A FI935066A FI935066L FI 935066 L FI935066 L FI 935066L FI 935066 A FI935066 A FI 935066A FI 935066 A FI935066 A FI 935066A FI 935066 L FI935066 L FI 935066L
Authority
FI
Finland
Prior art keywords
dem
tetrahydronaphthalenderivat
inverkande
farmaceutiska
cardiovascularsystemet
Prior art date
Application number
FI935066A
Other languages
English (en)
Other versions
FI935066A7 (fi
FI935066A0 (fi
Inventor
Francesco Santangelo
Giorgio Bertolini
Cesare Casagrande
Francesco Marchini
Stefania Montanari
Claudio Semeraro
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of FI935066L publication Critical patent/FI935066L/fi
Publication of FI935066A7 publication Critical patent/FI935066A7/fi
Publication of FI935066A0 publication Critical patent/FI935066A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/20Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/40Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/42Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/44Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
FI935066A 1992-03-17 1993-03-13 2-amino-1,2,3,4-tetrahydronaftalenderivat aktivt inverkande pao kardiovaskularsystemet, foerfaranden foer framstaellning av dem och farmaceutiska kompositioner innehaollande dem FI935066A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI920608A IT1254521B (it) 1992-03-17 1992-03-17 Derivati della 2-ammino-tetralina attivi sul sistema cardiovascolare
PCT/EP1993/000577 WO1993019036A1 (en) 1992-03-17 1993-03-13 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them

Publications (3)

Publication Number Publication Date
FI935066L true FI935066L (fi) 1993-11-16
FI935066A7 FI935066A7 (fi) 1993-11-16
FI935066A0 FI935066A0 (fi) 1993-11-16

Family

ID=11362451

Family Applications (1)

Application Number Title Priority Date Filing Date
FI935066A FI935066A0 (fi) 1992-03-17 1993-03-13 2-amino-1,2,3,4-tetrahydronaftalenderivat aktivt inverkande pao kardiovaskularsystemet, foerfaranden foer framstaellning av dem och farmaceutiska kompositioner innehaollande dem

Country Status (20)

Country Link
US (2) US5407956A (fi)
EP (1) EP0585440B1 (fi)
JP (1) JP3231775B2 (fi)
KR (1) KR100283945B1 (fi)
AT (1) ATE137737T1 (fi)
CA (1) CA2102490C (fi)
DE (1) DE69302544T2 (fi)
DK (1) DK0585440T3 (fi)
ES (1) ES2087729T3 (fi)
FI (1) FI935066A0 (fi)
GR (1) GR3020419T3 (fi)
HU (2) HUT68936A (fi)
IT (1) IT1254521B (fi)
MD (1) MD1449G2 (fi)
NO (1) NO180230C (fi)
NZ (1) NZ249845A (fi)
OA (1) OA09843A (fi)
PL (2) PL171844B1 (fi)
RU (1) RU2120435C1 (fi)
WO (1) WO1993019036A1 (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1271411B (it) * 1993-09-14 1997-05-28 Zambon Spa Derivati del 2-ammino-1,2,3,4-tetraidro-naftalene attivi sul sistema cardiovascolare
IT1274673B (it) * 1994-04-14 1997-07-24 Zambon Spa Derivati dell'acido fosfonico utili nel trattamento delle malattie car.iovascolari
IT1270260B (it) * 1994-06-21 1997-04-29 Zambon Spa Derivati dell'acido fosfonico ad attivita' inibitrice delle metallopeptidasi
IT1271007B (it) * 1994-09-13 1997-05-26 Zambon Spa Derivati del 2-ammino-1,2,3,4-tetraidronaftalene attivi sul sistema cardiovascolare
IT1271009B (it) * 1994-09-13 1997-05-26 Zambon Spa Derivati del benzopirano e del benzotiopirano attivi sul sistema cardiovascolare
IT1271008B (it) * 1994-09-13 1997-05-26 Zambon Spa Derivati del 2-ammino-1,2,3,4-tetraidro-naftalene attivi sul sistema cardiovascolare
IT1273455B (it) * 1995-01-27 1997-07-08 Zambon Spa Derivati tiolici ad attivita' inibitrice delle metallopeptidasi
IT1276710B1 (it) * 1995-06-14 1997-11-03 Zambon Spa Derivati dell'acido fosfinico ad attivita' inibitrice delle metallopeptidasi
GB9625455D0 (en) * 1996-12-07 1997-01-22 Glaxo Group Ltd Process for resolving mixtures of carbocyclic steroisomers
IT1289980B1 (it) 1997-02-26 1998-10-19 Zambon Spa Derivati idrossimetilici del 2-ammino-1,2,3,4-tetraidronaftalene attivi in campo cardiovascolare
JP5748666B2 (ja) * 2008-12-09 2015-07-15 インテルキム、ソシエダッド アノニマ (6s)−(−)−5,6,7,8−テトラヒドロ−6−[プロピル−(2−チエニル)エチル]アミノ−1−ナフトール(ロチゴチン)の製造のための方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0072061B1 (en) * 1981-08-05 1985-05-15 FISONS plc Amine derivatives, processes for their production and pharmaceutical compositions containing them
EP0142283B1 (en) * 1983-10-25 1991-01-30 FISONS plc Phenylethylamines, process for their preparation and compositions containing them
IT1224405B (it) * 1987-12-23 1990-10-04 Simes Composti attivi sul sistema cardiovascolare

Also Published As

Publication number Publication date
ITMI920608A0 (it) 1992-03-17
US5407956A (en) 1995-04-18
RU2120435C1 (ru) 1998-10-20
PL172056B1 (pl) 1997-07-31
NO934160D0 (no) 1993-11-17
CA2102490A1 (en) 1993-09-18
CA2102490C (en) 2004-06-08
HU211517A9 (en) 1995-11-28
PL171844B1 (pl) 1997-06-30
FI935066A7 (fi) 1993-11-16
NO934160L (no) 1993-11-17
MD1449F1 (en) 2000-04-30
EP0585440A1 (en) 1994-03-09
DE69302544D1 (de) 1996-06-13
DK0585440T3 (da) 1996-06-10
ATE137737T1 (de) 1996-05-15
DE69302544T2 (de) 1996-09-19
AU650201B2 (en) 1994-06-09
NZ249845A (en) 1996-03-26
NO180230B (no) 1996-12-02
NO180230C (no) 1997-03-12
MD1449G2 (ro) 2000-12-31
OA09843A (en) 1994-08-15
ITMI920608A1 (it) 1993-09-17
ES2087729T3 (es) 1996-07-16
JP3231775B2 (ja) 2001-11-26
HUT68936A (en) 1995-08-28
JPH06507920A (ja) 1994-09-08
US5451608A (en) 1995-09-19
EP0585440B1 (en) 1996-05-08
IT1254521B (it) 1995-09-25
MD960271A (en) 1997-09-30
FI935066A0 (fi) 1993-11-16
KR100283945B1 (ko) 2001-03-02
WO1993019036A1 (en) 1993-09-30
GR3020419T3 (en) 1996-10-31
AU3747893A (en) 1993-10-21

Similar Documents

Publication Publication Date Title
FI934440L (fi) Fibrintaeckmedelskompositioner och foerfaranden foer anvaendning av dem
FI930406L (fi) Pao foerhand fyllda handsprutor, behaollare och laekemedelsflaskor samt foerfarande foer slutsterilisering av desamma
FI934622L (fi) Foerfarande foer rengoering av amylas, pao sao saett framstaelld rengjord amylas och anvaendningar av rengjord amylas
FI935174L (fi) Tumoeravstoetande antigenprekursorer, tumoeravstoetande antigener och anvaendning av dem
FI922474L (fi) Nedbrytbara sulfonatgrupphaltiga kelatmedel, anvaendning av dem och kompositioner innehaollande dem
FI931763L (fi) 4,1-bensoxazepinderivat och deras anvaendning
FI932660L (fi) Vaermefoerseglingsbara, antistatiska belagda folier och folielaminat, foerfarande foer framstaellning av dessa och anvaendning av dessa
FI932718A7 (fi) Aotervinning av raoaemnen ur pappersindustrins avlut och aoteranvaendning av dem
FI932255L (fi) Alkalinproteaser, bakterier producerande dem, foerfarande foer framstaellning av dessa alkalinproteaser, anvaendning av dessa alkalinproteaser och tvaettmedelskompositioner innehaollande dem
FI932625A7 (fi) Anordning och foerfarande foer detektering av ytfel i laonga, i roerelse befintliga metallprodukter
FI933903A7 (fi) Substituerade cyklohexanderivat, foerfarande foer framstaellning daerav och anvaendning av foereningar foer behandling av sjukdomar
FI930974L (fi) Substituerade aminofosfonatderivat, foerfarande foer framstaellning av desamma och farmaceutiska kompositioner innehaollande desamma
FI931291L (fi) Indol- och indazolderivat foer behandling och foerebyggande av hjaernsjukdomar, deras framstaellning och anvaendning
FI923170A7 (fi) Spicamycinderivat och anvaendning av dem
FI935829A0 (fi) Anlaeggning och foerfarande foer uttnyttjning av braennbara aemnen, speciellt industri- och hushaollsavfall
FI935066L (fi) 2-amino-1,2,3,4-tetrahydronaftalenderivat aktivt inverkande pao kardiovaskularsystemet, foerfaranden foer framstaellning av dem och farmaceutiska kompositioner innehaollande dem
FI930130L (fi) Bundet fiberknippe, foerfarande foer framstaellning av detta och daerav erhaollna textilytstrukturer
FI930717A7 (fi) 4-amino-2-ureido-pyrimidin-5-karboxylsyraamider, foerfarande foer framstaellning av dessa, laekemedel innehaollande dessa och deras anvaendning
FI933544A0 (fi) Tiadiazinkarboxamidderivat, foerfaranden foer framstaellning av dem och laekemedel
FI932951L (fi) Tillsatskonsentrat innehaollande sulfurerat jordalkalimetallhydrokarbylfenat, foerfarande foer framstaellning av detta och anvaendning av detta
FI911759A0 (fi) Automatisk maskin foer montering av slutbleck pao foenster- och foensterdoerrkarmar.
FI933605A0 (fi) Sammansaettningar av 1-klor-2,2,2-trifluoretyldifluormetyleter och partiellt fluorerade alkanoler
FI932750L (fi) Kaoda nedbrytande svampar och preparation av dem
FI935196A0 (fi) Pyrrolderivat, framstaellning av dem och anvaendning av dem vid terapi
FI930117L (fi) Blandningar av 1,1,1-trifluoretan och perfluorpropan och deras anvaendning som kylvaetskor, som aerosoldrivgaser och som expansionsmedel foer plastskum